Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Am J Physiol Lung Cell Mol Physiol. 2012 Sep 15;303(6):L550-5. doi: 10.1152/ajplung.00190.2012. Epub 2012 Jul 20.
The rate of alveolar fluid clearance (AFC) is associated with mortality in clinical acute lung injury (ALI). Patients with ALI often develop circulatory shock, but how shock affects the rate of AFC is unknown. To determine the effect of circulatory shock on the rate of AFC in patients with ALI, the rate of net AFC was measured in 116 patients with ALI by serial sampling of pulmonary edema fluid. The primary outcome was the rate of AFC in patients with shock compared with those without shock. We also tested the effects of shock severity and bacteremia. Patients with ALI and shock (n = 86) had significantly slower rates of net AFC compared with those without shock (n = 30, P = 0.03), and AFC decreased significantly as the number of vasopressors increased. Patients with positive blood cultures (n = 21) had slower AFC compared with patients with negative blood cultures (n = 96, P = 0.023). In addition, the edema fluid-to-plasma protein ratio, an index of alveolar-capillary barrier permeability, was highest in patients requiring the most vasopressors (P < 0.05). Patients with ALI complicated by circulatory shock and bacteremia had slower rates of AFC compared with patients without shock or bacteremia. An impaired capacity to reabsorb alveolar edema fluid may contribute to high mortality among patients with sepsis-induced ALI. These findings also suggest that vasopressor use may be a marker of alveolar-capillary barrier permeability in ALI and provide justification for new therapies that enhance alveolar epithelial and endothelial barrier integrity in ALI, particularly in patients with shock.
肺泡液体清除率(AFC)的速率与临床急性肺损伤(ALI)患者的死亡率相关。ALI 患者常发生循环性休克,但休克如何影响 AFC 速率尚不清楚。为了确定循环性休克对 ALI 患者 AFC 速率的影响,通过对肺水肿液进行连续采样,测量了 116 例 ALI 患者的净 AFC 速率。主要结局是休克患者与无休克患者的 AFC 速率比较。我们还测试了休克严重程度和菌血症的影响。与无休克患者(n=30)相比,患有 ALI 和休克的患者(n=86)的净 AFC 速率明显较慢(P=0.03),并且随着血管加压药使用数量的增加,AFC 显著降低。血培养阳性的患者(n=21)的 AFC 比血培养阴性的患者(n=96)更慢(P=0.023)。此外,作为肺泡毛细血管屏障通透性的指标,需要使用最多血管加压药的患者的水肿液-血浆蛋白比率最高(P<0.05)。与无休克或菌血症的患者相比,并发循环性休克和菌血症的 ALI 患者的 AFC 速率较慢。肺泡上皮和内皮屏障完整性受损,可能导致脓毒症引起的 ALI 患者死亡率较高。这些发现还表明,血管加压药的使用可能是 ALI 中肺泡毛细血管屏障通透性的标志物,并为增强 ALI 中肺泡上皮和内皮屏障完整性的新疗法提供了依据,尤其是在休克患者中。